Genprex Inc (GNPX)
2.32
+0.05
(+2.20%)
USD |
NASDAQ |
May 01, 16:00
2.32
0.00 (0.00%)
After-Hours: 20:00
Genprex Cash and Short Term Investments (Quarterly): 6.738M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.738M |
| September 30, 2023 | 11.71M |
| June 30, 2023 | 9.956M |
| March 31, 2023 | 18.08M |
| December 31, 2022 | 20.95M |
| September 30, 2022 | 25.52M |
| June 30, 2022 | 30.05M |
| March 31, 2022 | 34.56M |
| December 31, 2021 | 38.63M |
| September 30, 2021 | 42.02M |
| June 30, 2021 | 44.24M |
| March 31, 2021 | 47.07M |
| December 31, 2020 | 27.32M |
| September 30, 2020 | 21.06M |
| June 30, 2020 | 22.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 23.08M |
| December 31, 2019 | 2.002M |
| September 30, 2019 | 2.548M |
| June 30, 2019 | 4.496M |
| March 31, 2019 | 6.946M |
| December 31, 2018 | 8.601M |
| September 30, 2018 | 10.31M |
| June 30, 2018 | 12.00M |
| March 31, 2018 | 0.0245M |
| December 31, 2017 | 0.1613M |
| September 30, 2017 | 0.3739M |
| June 30, 2017 | 0.4679M |
| March 31, 2017 | 0.93M |
| December 31, 2016 | 1.602M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.002M
Minimum
Dec 2019
47.07M
Maximum
Mar 2021
22.75M
Average
22.13M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Jaguar Health Inc | 6.469M |
| FibroGen Inc | 235.59M |
| BioXcel Therapeutics Inc | 65.22M |
| TFF Pharmaceuticals Inc | 5.478M |
| 4D Molecular Therapeutics Inc | 288.23M |